Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Azelby Robert
Relationship:   Director
City:   Seattle
State:   WA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   58,011    

Indirect Shares

  0      
Direct Value   $621,991    

Indirect Value

  $0      
Total Shares   58,011      
Total Value   $621,991      


Immunomedics Inc
 $326,663 ADC Therapeutics Sa
 $156,365 Cardinal Health Inc
 $138,962 Immunomedics Inc
 $326,663 ADC Therapeutics Sa
 $156,365 Cardinal Health Inc
 $138,962
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    1    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   1.0   
     Percentage Gain/Loss :
     0.0%
 2.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Juno Therapeutics, Inc. JUNO EVP & Chief Commercial... 2018-03-05 0 2015-11-01 0    Premium*  
            Immunomedics Inc IMMU Director 2020-06-18 3,718 2020-06-18 0    Premium*  
            ADC Therapeutics Sa ADCT Director 2024-06-17 53,005 0    Premium*  
            Cardinal Health Inc CAH Director 2024-03-15 1,288 2024-03-15 0    Premium*  
* Premium Members only  

Records found :    29         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ADCT ADC Therapeutics Sa Director   –       •      –    2024-01-02 3 IO $0.00 $0 D/D 0 20,000 %
ADCT ADC Therapeutics Sa Director   –       •      –    2024-06-13 4 A $0.00 $0 D/D 40,000 60,000 0 -
ADCT ADC Therapeutics Sa Director   –       •      –    2024-06-17 4 S $2.89 $20,216 D/D (6,995) 53,005 0 %
CAH Cardinal Health Inc Director   –       •      –    2024-03-15 4 A $0.00 $0 D/D 1,288 1,288 0 -
IMMU Immunomedics Inc Director   –       •      –    2020-06-18 4 A $0.00 $0 D/D 3,718 3,718 0 -
JUNO Juno Therapeutics, Inc. See Remarks   •       –      –    2015-11-01 4 A $0.00 $0 D/D 38,640 38,640 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2016-11-08 4 A $0.00 $0 D/D 10,000 48,640 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2016-11-10 4 AS $24.14 $311,848 D/D (12,921) 35,719 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2017-02-07 4 A $0.00 $0 D/D 27,439 63,158 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2017-08-29 4 AS $39.95 $514,117 D/D (12,869) 50,289 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2017-09-13 4 AS $44.95 $577,608 D/D (12,850) 37,439 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2017-10-20 4 A $0.00 $0 D/D 35,893 73,332 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2017-11-02 4 AS $54.95 $366,297 D/D (6,666) 73,332 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2017-11-02 4 OE $25.29 $168,583 D/D 6,666 79,998 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2017-11-08 4 D $55.98 $38,290 D/D (684) 72,648 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2017-12-18 4 AS $44.96 $81,647 D/D (1,816) 70,832 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-01-17 4 AS $68.10 $1,998,603 D/D (29,131) 70,832 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-01-17 4 OE $20.76 $616,076 D/D 29,131 99,963 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-01-22 4 AS $86.25 $8,843,989 D/D (102,539) 70,832 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-01-22 4 OE $51.76 $5,307,419 D/D 102,539 173,371 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-01-31 4 A $0.00 $0 D/D 25,639 96,471 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-02-01 4 AS $85.78 $357,445 D/D (4,167) 96,471 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-02-01 4 OE $51.76 $215,684 D/D 4,167 100,638 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-02-07 4 D $85.49 $230,823 D/D (2,700) 93,771 0 -
JUNO Juno Therapeutics, Inc. EVP & Chief Commercial Officer   •       –      –    2018-02-08 4 AS $85.77 $299,938 D/D (3,497) 93,771 0 -

  29  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed